Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,201 to 2,220 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| C1-esterase inhibitor enhances thrombin generation and spatial fibrin clot propagation in the presence of thrombomodulin. | Thromb Res | 2019 | 30784776 | PubTator, text mining | PubMed |
| Application of protein chip combined with SELDI-TOF-MS detection to investigate serum protein expression in patients with silicosis fibrosis. | Exp Ther Med | 2019 | 30783481 | PubTator, text mining | PubMed |
| Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India. | Front Immunol | 2019 | 30778343 | PubTator, text mining | PubMed |
| Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. | J Allergy Clin Immunol Pract | 2019 | 30772477 | PubTator, text mining | PubMed |
| Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use. | Front Immunol | 2019 | 30740097 | PubTator, text mining | PubMed |
| Regional protein expression in human Alzheimer's brain correlates with disease severity. | Commun Biol | 2019 | 30729181 | PubTator, text mining | PubMed |
| A Forgotten Cause of Allergy at ER That Is Still Difficult to Diagnose and Treat at Poor Resource Setting: Angioedema after Using Angiotensin Converting Enzyme Inhibitors for 4 Years. | Case Reports Immunol | 2019 | 30723559 | PubTator, text mining | PubMed |
| C1-INH concentrate for prophylaxis during pregnancy in hereditary angioedema with normal C1-INH. | J Allergy Clin Immunol Pract | 2019 | 30717879 | PubTator, text mining | PubMed |
| Complement and Transplantation: From New Mechanisms to Potential Biomarkers and Novel Treatment Strategies. | Clin Lab Med | 2019 | 30709507 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism. | Sci Rep | 2019 | 30705326 | PubTator, text mining | PubMed |
| Angioedema after thrombolysis with tissue plasminogen activator: an airway emergency. | Oxf Med Case Reports | 2019 | 30697429 | PubTator, text mining | PubMed |
| Oxidative stress markers in patients with hereditary angioedema. | Arch Med Sci | 2019 | 30697258 | PubTator, text mining | PubMed |
| Analysis of genetic polymorphisms for age-related macular degeneration (AMD) in Chinese Tujia ethnic minority group. | BMC Med Genet | 2019 | 30696427 | PubTator, text mining | PubMed |
| White Matter is the Predilection Site of Late-Delayed Radiation-Induced Brain Injury in Non-Human Primates. | Radiat Res | 2019 | 30694733 | PubTator, text mining | PubMed |
| Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis. | J Clin Med | 2019 | 30691103 | PubTator, text mining | PubMed |
| SERPING1 exon 3 splicing variants using alternative acceptor splice sites. | Mol Immunol | 2019 | 30685616 | PubTator, text mining | PubMed |
| Human pluripotent stem cell-derived alveolar epithelial cells are alternatives for in vitro pulmotoxicity assessment. | Sci Rep | 2019 | 30679658 | PubTator, text mining | PubMed |
A Retrospective Analysis of the Cartilage Kunitz Protease Inhibitory Proteins Identifies These as Members of the Inter-α-Trypsin Inhibitor Superfamily with Potential Roles in the Protection of the Articulatory Surface. | Int J Mol Sci | 2019 | 30678366 | PubTator, text mining | PubMed |
| Hereditary angioedema: Linking complement regulation to the coagulation system. | Res Pract Thromb Haemost | 2019 | 30656274 | PubTator, text mining | PubMed |
| Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer. | Pharmaceutics | 2019 | 30650541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=111